<DOC>
	<DOCNO>NCT03101189</DOCNO>
	<brief_summary>So far , ACT-541468 study mainly Caucasian subject . The present study bridge result obtain Caucasian subject Japanese subject .</brief_summary>
	<brief_title>A Study ACT-541468 Healthy Japanese Caucasian Subjects</brief_title>
	<detailed_description />
	<criteria>Key Signed informed consent form ; Healthy male female subject age 20 50 year ( inclusive ) screening ; Negative serum pregnancy test screen negative urine pregnancy test Day 1 woman childbearing potential agreement use reliable method contraception least 90 day last study drug intake ; Body mass index ( BMI ) 18.0 26.0 kg/m2 ( inclusive ) screening ; Healthy basis physical examination , cardiovascular assessment laboratory test ; Caucasian Japanese ethnicity . Japanese subject : must native Japanese descent ( parents/grandparents Japanese descent ) ; must away Japan 10 year ( screen visit ) ; lifestyle change significantly since relocation Japan . Key Any contraindication study treatment ; History clinical evidence disease medical / surgical condition treatment , may put subject risk participation study may interfere absorption , distribution , metabolism excretion study treatment ; History narcolepsy cataplexy modify Swiss narcolepsy scale total score &lt; 0 ; Any circumstance condition , , opinion investigator , may affect full participation study compliance protocol .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>safety</keyword>
	<keyword>Japanese</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>